SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-065384
Filing Date
2023-03-09
Accepted
2023-03-09 08:32:31
Documents
7
Effectiveness Date
2023-03-09

Document Format Files

Seq Description Document Type Size
1 S-8 d481903ds8.htm S-8 50366
2 EX-5.1 d481903dex51.htm EX-5.1 4064
3 EX-23.2 d481903dex232.htm EX-23.2 2393
4 EX-99.1 d481903dex991.htm EX-99.1 26999
5 EX-FILING FEES d481903dexfilingfees.htm EX-FILING FEES 52789
6 GRAPHIC g481903g0308131201221.jpg GRAPHIC 2247
7 GRAPHIC g481903g65q01.jpg GRAPHIC 14756
  Complete submission text file 0001193125-23-065384.txt   156131
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270387 | Film No.: 23718290
SIC: 2836 Biological Products, (No Diagnostic Substances)